BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9925232)

  • 1. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study.
    Mayer T; Schütte W; Wolf P; Elger CE
    Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV)].
    Rajna P; Szíjártó E
    Ideggyogy Sz; 2006 Sep; 59(9-10):361-72. PubMed ID: 17165379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
    Korn-Merker E; Borusiak P; Boenigk HE
    Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
    Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients.
    Wilson EA; Sills GJ; Forrest G; Brodie MJ
    Epilepsy Res; 1998 Jan; 29(2):161-6. PubMed ID: 9477149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
    Bruni J
    Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E
    Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
    Rejdak K; Lipa A; Kaczyński K; Stelmasiak Z;
    Wiad Lek; 2011; 64(2):91-6. PubMed ID: 22026272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
    Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin in refractory partial epilepsy--a trial in India.
    Dixit SN; Jain S; Padma MV; Maheshwari MC
    Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study of Gabapentin in the treatment of partial seizures.
    Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
    Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
    Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
    Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.